Activist Investor Ananym Urges Bio-Techne to Consider Selling

Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a strategic review that would include a potential sale.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.